CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 104 enrolled
Drug / intervention
Minimally invasive extracorporeal circulation (MiECC) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02672514
NCT02672514N/ACompleted
CompareCT.gov

Does Minimal Extracorporeal Circulation Improve Outcome in Diabetic Patients Undergoing Elective Coronary Bypass Grafting?

Herzzentrum Coswig·interventional·Posted Feb 3, 2016·Updated Mar 27, 2017

In Brief

A clinical study evaluating Minimally invasive extracorporeal circulation (MiECC) and Conventional extracorporeal circulation (CECC) for Acute Kidney Injury. Completed, enrolled 104 participants.

Detailed Summary

The aim of this study was to prospectively evaluate MECC compared with conventional extracorporeal circulation of diabetic patients undergoing elective coronary revascularization procedures. The investigators focused on the effects of extracorporeal circulation especially the renal function between both groups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Kidney Injury
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 3, 2016
Enrollment StartFeb 1, 2010
Primary CompletionApr 1, 2012
Study CompletionJun 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 10.4 years ago

Interventions

Minimally invasive extracorporeal circulation (MiECC)device

Minimally invasive extracorporeal circulation (MiECC) is an extracorporeal circulation systems used for cardiopulmonary bypass.

Conventional extracorporeal circulation (CECC)device

Conventional extracorporeal circulation (CECC) is an extracorporeal circulation system used for cardiopulmonary bypass.